53 related articles for article (PubMed ID: 25947085)
1. Proteasome inhibitor PS-341 induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling.
Yang Y; Ikezoe T; Saito T; Kobayashi M; Koeffler HP; Taguchi H
Cancer Sci; 2004 Feb; 95(2):176-80. PubMed ID: 14965369
[TBL] [Abstract][Full Text] [Related]
2. A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin-induced apoptosis in castration-resistant prostate cancer.
Ye PC; Leu WJ; Yeh TY; Hsu YT; Lin YC; Wei ZY; Chen YC; Chiang YC; Hsu JL; Chan SH; Hsu LC; Chern JW; Yu CW; Guh JH
Prostate; 2024 May; 84(6):605-619. PubMed ID: 38375594
[TBL] [Abstract][Full Text] [Related]
3. Failure to induce apoptosis via BCL-2 family proteins underlies lack of efficacy of combined MEK and PI3K inhibitors for KRAS-mutant lung cancers.
Hata AN; Yeo A; Faber AC; Lifshits E; Chen Z; Cheng KA; Walton Z; Sarosiek KA; Letai A; Heist RS; Mino-Kenudson M; Wong KK; Engelman JA
Cancer Res; 2014 Jun; 74(11):3146-56. PubMed ID: 24675361
[TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinase 1-mediated phosphorylation of YES links mitotic arrest and apoptosis during antitubulin chemotherapy.
Wang Z; Chen X; Zhong MZ; Yang S; Zhou J; Klinkebiel DL; Karpf AR; Chen Y; Dong J
Cell Signal; 2018 Dec; 52():137-146. PubMed ID: 30223016
[TBL] [Abstract][Full Text] [Related]
5. Obtusilactone A and (-)-sesamin induce apoptosis in human lung cancer cells by inhibiting mitochondrial Lon protease and activating DNA damage checkpoints.
Wang HM; Cheng KC; Lin CJ; Hsu SW; Fang WC; Hsu TF; Chiu CC; Chang HW; Hsu CH; Lee AY
Cancer Sci; 2010 Dec; 101(12):2612-20. PubMed ID: 21077998
[TBL] [Abstract][Full Text] [Related]
6. The anti-non-small cell lung cancer effect of Diosbulbin B: Targeting YY1 induced cell cycle arrest and apoptosis.
Zhao JQ; Zhou QQ; Sun Y; Yu T; Jiang Y; Li HJ
Phytomedicine; 2024 May; 130():155734. PubMed ID: 38761775
[TBL] [Abstract][Full Text] [Related]
7. Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy.
Herrmann J; Elnakady YA; Wiedmann RM; Ullrich A; Rohde M; Kazmaier U; Vollmar AM; Müller R
PLoS One; 2012; 7(5):e37416. PubMed ID: 22616003
[TBL] [Abstract][Full Text] [Related]
8. A Novel 2-Methoxyestradiol Derivative: Disrupting Mitosis Inhibiting Cell Motility and Inducing Apoptosis in HeLa Cells In Vitro.
Njangiru IK; Bózsity-Faragó N; Resch VE; Paragi G; Frank É; Balogh GT; Zupkó I; Minorics R
Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794284
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of alpha-mannosidase Man2c1 gene expression suppresses growth of esophageal carcinoma cells through mitotic arrest and apoptosis.
Tian Y; Ju JY; Zhou YQ; Liu Y; Zhu LP
Cancer Sci; 2008 Dec; 99(12):2428-34. PubMed ID: 19018777
[TBL] [Abstract][Full Text] [Related]
10. FAM172A affects cell proliferation and apoptosis not by targeting β-tubulin in HepG2 cells.
Xu AM; He CJ; Tuerxun Z; Anikezi A
Transl Cancer Res; 2020 Sep; 9(9):5637-5644. PubMed ID: 35117927
[TBL] [Abstract][Full Text] [Related]
11. The role of anti-angiogenesis in non-small-cell lung cancer: an update.
Villaruz LC; Socinski MA
Curr Oncol Rep; 2015 Jun; 17(6):26. PubMed ID: 25947099
[TBL] [Abstract][Full Text] [Related]
12. First total synthesis, antitumor evaluation and target identification of mornaphthoate E: A new tubulin inhibitor template acting on PI3K/Akt signaling pathway.
Shan P; Ye T; Tang YD; Song H; Wang C; Zhu K; Yang F; Zhang SL; Su PW; Gao S; Zhang H
Acta Pharm Sin B; 2024 May; 14(5):2177-2193. PubMed ID: 38799630
[TBL] [Abstract][Full Text] [Related]
13. Design and Synthesis of Novel α-Methylchalcone Derivatives, Anti-Cervical Cancer Activity, and Reversal of Drug Resistance in HeLa/DDP Cells.
Yang Z; Liu Z; Ablise M; Maimaiti A; Aihaiti A; Alimujiang Y
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067428
[TBL] [Abstract][Full Text] [Related]
14. S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer.
Hou Z; Lin S; Du T; Wang M; Wang W; You S; Xue N; Liu Y; Ji M; Xu H; Chen X
Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242532
[TBL] [Abstract][Full Text] [Related]
15. Isoferulic acid inhibits human leukemia cell growth through induction of G2/M‑phase arrest and inhibition of Akt/mTOR signaling.
Long Z; Feng G; Zhao N; Wu L; Zhu H
Mol Med Rep; 2020 Mar; 21(3):1035-1042. PubMed ID: 31922221
[TBL] [Abstract][Full Text] [Related]
16. Shortest path counting in probabilistic biological networks.
Ren Y; Ay A; Kahveci T
BMC Bioinformatics; 2018 Dec; 19(1):465. PubMed ID: 30514202
[TBL] [Abstract][Full Text] [Related]
17. In silico identification of potential key regulatory factors in smoking-induced lung cancer.
El-Aarag SA; Mahmoud A; Hashem MH; Abd Elkader H; Hemeida AE; ElHefnawi M
BMC Med Genomics; 2017 Jun; 10(1):40. PubMed ID: 28592245
[TBL] [Abstract][Full Text] [Related]
18. CSC-3436 switched tamoxifen-induced autophagy to apoptosis through the inhibition of AMPK/mTOR pathway.
Wu ST; Sun GH; Cha TL; Kao CC; Chang SY; Kuo SC; Way TD
J Biomed Sci; 2016 Aug; 23(1):60. PubMed ID: 27526942
[TBL] [Abstract][Full Text] [Related]
19. The newly synthesized 2-arylnaphthyridin-4-one, CSC-3436, induces apoptosis of non-small cell lung cancer cells by inhibiting tubulin dynamics and activating CDK1.
Chang LC; Yu YL; Liu CY; Cheng YY; Chou RH; Hsieh MT; Lin HY; Hung HY; Huang LJ; Wu YC; Kuo SC
Cancer Chemother Pharmacol; 2015 Jun; 75(6):1303-15. PubMed ID: 25947085
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
